Test Price
2,100 AED✅ Home Collection Available
Diabetes Type 1 Autoimmune Profile Test in UAE | 2100 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Complimentary post-test telephonic clinical interpretation support.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
This advanced autoimmune profile detects islet-cell autoantibodies years before clinical hyperglycemia appears, enabling early intervention and precise differentiation between Type 1 and Type 2 diabetes. The panel targets GAD65, IA-2, insulin autoantibodies (IAA), and ZnT8 using dual-platform ELISA/IFA technology with next-day reporting.
Test Overview & Methodology
The Diabetes Type 1 Autoimmune Profile quantifies four key islet-specific autoantibodies that signal autoimmune destruction of pancreatic beta cells. The panel employs fully automated enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence assay (IFA) on dual-platform instrumentation, providing high specificity and sensitivity for early-stage Type 1 diabetes detection in both adult and paediatric populations.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | ELISA/IFA dual-platform with ISO 9001 validation; includes ZnT8 and IAA isoforms | Partial panel (e.g., GAD only) often without isoform-specific assays |
| Speed | Sample by Friday 9 AM → Report next day | Results in 3–5 working days |
| Methodology | Fully automated ELISA and IFA with comprehensive four-antibody panel | HbA1c/glucose metabolic markers only; no autoimmune profiling |
Physician Insight & Safety Protocols
“Positive autoantibodies in this profile indicate an ongoing autoimmune process against pancreatic beta cells and are strongly associated with progression to clinical Type 1 Diabetes. However, results must be interpreted alongside glucose tolerance testing, C-peptide levels, and the patient’s clinical presentation. This panel serves as a critical early warning tool and should never be used as a standalone diagnostic criterion.”
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Medication Safety Advisory
Patients currently prescribed insulin or oral hypoglycaemic agents must not discontinue or alter their medication regimen without direct consultation with their treating physician. Abrupt cessation of diabetes therapy can precipitate diabetic ketoacidosis, severe hyperglycaemia, or other acute metabolic complications. This test does not replace ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Acute febrile illness, recent major surgery within the past four weeks, pregnancy beyond the first trimester (interpret results with caution). Testing should be deferred until the patient is clinically stable.
- Emergency Red Flags: Rapid deep breathing, fruity odour on breath, confusion or altered mental status, severe abdominal pain, or unexplained vomiting — these symptoms warrant immediate emergency medical evaluation.
Patient FAQ & Clinical Guidance
1. What does the Diabetes Type 1 Autoimmune Profile measure and why is it needed?
The profile quantifies four islet-specific autoantibodies — GAD65, IA-2, insulin autoantibodies (IAA), and ZnT8 — that indicate autoimmune-mediated beta-cell destruction. These antibodies can appear in the bloodstream months to years before blood glucose levels rise, making this panel essential for early detection and prevention of diabetic ketoacidosis at onset.
2. How should I prepare for the test and what is the sample collection process?
No fasting or special preparation is required. A 5 mL serum sample (minimum 3 mL) is collected via standard venipuncture into an SST tube. Our temperature-controlled cold-chain logistics team ensures the specimen remains refrigerated during transport. VIP Mobile Phlebotomy is available daily from 8 AM to 11 PM for home collection across Dubai and the Northern Emirates.
3. When will I receive my results and what follow-up support is included?
Reports are delivered the next calendar day when the sample reaches our laboratory by Friday 9 AM. Each result includes a complimentary telephonic consultation with a clinical specialist who will explain the autoantibody findings, discuss their implications for diabetes risk stratification, and coordinate any necessary referral to an endocrinologist.
4. Can this test distinguish between Type 1 and Type 2 Diabetes definitively?
A positive result for one or more autoantibodies strongly supports a diagnosis of autoimmune Type 1 Diabetes rather than Type 2. However, a small percentage of individuals with Type 2 Diabetes may also exhibit low-level positivity. Correlation with clinical phenotype, C-peptide levels, and glucose tolerance testing is always required for definitive classification.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, access-controlled, and processed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139). Clinical safety and informed consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DHA Facility License: 1143. For privacy inquiries or data subject access requests, contact our Data Protection Officer via WhatsApp at +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | Diabetes Type 1 Autoimmune Profile |
| Price (AED) | 2,100 AED |
| Turnaround Time | 24 hours (next day report when sample received by Friday 9 AM) |
| Sample Type / Matrix | Serum (peripheral whole blood) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM to 11 PM |
| Methodology Used | Fully automated Enzyme-Linked Immunosorbent Assay (ELISA) and Indirect Immunofluorescence Assay (IFA) on dual-platform instrumentation |
| ICD-10-CM Code | E10.9 |
| LOINC Code | 94053-4 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians